» Articles » PMID: 7898688

Magnetic Resonance Imaging in Brachial Plexopathy of Cancer

Overview
Journal Neurology
Specialty Neurology
Date 1995 Mar 1
PMID 7898688
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

We retrospectively reviewed the clinical records of all patients with cancer and brachial plexopathy who had an MRI of the brachial plexus between 1984 and 1993 (71 patients). The MRIs were reevaluated in a blinded fashion. The presence of a mass adjacent to the brachial plexus on MRI was highly predictive of tumor infiltration as determined by clinicopathologic criteria and was the most useful feature in distinguishing radiation plexopathy from tumor infiltration. Increased T2 signal in or near the brachial plexus was commonly seen in both groups and was not useful in this distinction. MRI was very sensitive for brachial plexus abnormalities in this condition, and limited comparison with CT suggested that MRI is superior to CT as an imaging modality. CT performed sufficiently well, however, to suggest that a prospective comparison study of the cost effectiveness and clinical utility of the two imaging modalities in this clinical setting is warranted.

Citing Articles

Advanced Imaging of the Peripheral Nerves, From the "How We Do It" Special Series.

Baal J, Yoon D, Patel R, Chin C, Shah V AJR Am J Roentgenol. 2024; 223(5):e2430826.

PMID: 38353448 PMC: 11855510. DOI: 10.2214/AJR.24.30826.


Intense F-Flourodeoxyglucose Uptake in Brachial Plexus of Patients with Brachial Plexopathy.

Soydal C, Akkus P, Araz M, Utkan G Mol Imaging Radionucl Ther. 2020; 29(2):79-81.

PMID: 32368879 PMC: 7201434. DOI: 10.4274/mirt.galenos.2019.40469.


Metastatic Brachial Plexopathy with Brain and Spinal Metastasis in a Case of Recurrent Breast Carcinoma Demonstrated on F-FDG PET/CT.

Gandhi S, Rabadiya B Indian J Nucl Med. 2017; 32(2):118-121.

PMID: 28533639 PMC: 5439204. DOI: 10.4103/0972-3919.202252.


Clinical Utility of (18)F-FDG PET/CT in brachial plexopathy secondary to metastatic breast cancer.

Chandra P, Purandare N, Agrawal A, Shah S, Rangarajan V Indian J Nucl Med. 2016; 31(2):123-7.

PMID: 27095861 PMC: 4815384. DOI: 10.4103/0972-3919.178263.


Diffusivity measurements differentiate benign from malignant lesions in patients with peripheral neuropathy or plexopathy.

Yuh E, Jain Palrecha S, Lagemann G, Kliot M, Weinstein P, Barbaro N AJNR Am J Neuroradiol. 2014; 36(1):202-9.

PMID: 25300985 PMC: 7965923. DOI: 10.3174/ajnr.A4080.